Evidence map›Paper›PMID 33893179›Full record

ArticleImmunoHorizons2021

Correlation of Regulatory T Cell Numbers with Disease Tolerance upon Virus Infection.

Jessica B Graham, Jessica L Swarts, Kristina R Edwards, Kathleen M Voss, Richard Green, Sophia Jeng, Darla R Miller, Michael A Mooney, Shannon K McWeeney, Martin T Ferris and 3 more

Open access · goldAbstract read
In one paragraph

Article in ImmunoHorizons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jessica B GrahamVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.ORCID 0000-0001-6579-0443
Jessica L SwartsVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Kristina R EdwardsVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.ORCID 0000-0002-2251-1448
Kathleen M VossCenter for Innate Immunity and Immune Disease, Department of Immunology, University of Washington School of Medicine, Seattle, WA.ORCID 0000-0003-1033-7670
Richard GreenCenter for Innate Immunity and Immune Disease, Department of Immunology, University of Washington School of Medicine, Seattle, WA.ORCID 0000-0001-8851-7204
Sophia JengDivision of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR.
Darla R MillerDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.ORCID 0000-0002-0781-7254
Michael A MooneyDivision of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR.
Shannon K McWeeneyDivision of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR.
Martin T FerrisDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Fernando Pardo-Manuel de VillenaDepartment of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC.ORCID 0000-0002-5738-5795
Michael GaleDivision of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR.
Jennifer M LundVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; jlund@fredhutch.org.ORCID 0000-0003-3284-979X
Infectious Disease Research Institute · USOregon Health & Science University · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
Unlocking Zika Virus Immune Control and Pathogenesis with the Collaborative CrossU19AI100625 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MCWEENEY, SHANNON K. · 2012 to 2021
$36.6M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Tissue Regulatory T Cells in Mucosal InfectionR01AI141435 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LUND, JENNIFER M · 2019 to 2023
$3.2M
NIAID NIH HHS R01 AI141435NIAID NIH HHS T32 AI007509NIAID NIH HHS U19 AI100625NIH HHS P51 OD010425
6 · The paper itself

Abstract

The goal of a successful immune response is to clear the pathogen while sparing host tissues from damage associated with pathogen replication and active immunity. Regulatory T cells (Treg) have been implicated in maintaining this balance as they contribute both to the organization of immune responses as well as restriction of inflammation and immune activation to limit immunopathology. To determine if Treg abundance prior to pathogen encounter can be used to predict the success of an antiviral immune response, we used genetically diverse mice from the collaborative cross infected with West Nile virus (WNV). We identified collaborative cross lines with extreme Treg abundance at steady state, either high or low, and used mice with these extreme phenotypes to demonstrate that baseline Treg quantity predicted the magnitude of the CD8 T cell response to WNV infection, although higher numbers of baseline Tregs were associated with reduced CD8 T cell functionality in terms of TNF and granzyme B expression. Finally, we found that abundance of CD44

Indexed as

AnimalsBrainCD8-Positive T-LymphocytesGranzymesImmune ToleranceMaleMiceSpleenT-Lymphocytes, RegulatoryTumor Necrosis Factor-alphaViral LoadWest Nile FeverWest Nile virusGranzymesTumor Necrosis Factor-alpha

Identifiers

PMID33893179
PMCPMC8281504
OpenAlexW3156441751

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.